Suppr超能文献

[波斯尼亚东北部的非霍奇金淋巴瘤——疾病生物学侵袭性及主要表现的变化]

[Non Hodgkin lymphoma in the North-East Bosnia--changes in biological aggressiveness and primary presentation of the disease].

作者信息

Halilbasić Alma, Mesic Enisa, Cikusić Elmir, Arnautović Aida

机构信息

Univerzitetski centar Tuzla, Trnovac.

出版信息

Med Arh. 2006;60(6 Suppl 2):78-83.

Abstract

INTRODUCTION

NHL are the group of lymphoproliferative neoplasms which incidence is in constant increase. The aim of the paper is the analysis of the immunophenotypes, clinical distribution and ways of primary presentation and biological aggressiveness of NHL in the North-East Bosnia. It especially illustrates the post war period from 1998 to 2002.

METHODS

Two hundred and twenty-eight patients with pathohistologically proved NHL are analysed in the paper. The tested group consisted of 142 patients with diagnosed NHL in the period between 1998 and 2002, and the control group consisted of 86 patients whose NHL was proved in the period between 1987 and 1991. These factors were analysed: immunophenotype NHL by immunohistochemical method of indirect three-stage immunoperoxidase with streptovidin, the type of NHL, the degree of biological aggressiveness of NHL, the way of primary presentation and the clinical phases of distribution of the disease according to the age, sex, profession and the habitat (urban or rural) of the patients. The prevalence and the incidence of the disease in the region of the North-East Bosnia was determined. The statistical analyses of the date was performed by the average values, standard deviations and chi2 test.

RESULTS

The total number of patients with NHL in the North-East Bosnia was quite bigger in the test group than in the control group with the incidence of 2.6/100,000 inhabitants in 1989, and 6.91/100,000 inhabitants in 2002. There were 80 men (56%) and 62 women (44%) in the test group, and 55 men (64%) and 31 women (36%) in the control group. The average age of the patients was 55.78 +/- -15.1 years. Statistically significant decrease of patients was noticed in the groups of industrial and agricultural workers in the test group comparing with the control group (9% against 15% and 4% against 19%, p < 0.005). At the same time the significant increase of the number of patients was found in the test group from the industrial regions of Lukavac (15 against 4 patients, p < 0.005), Tuzla (49 against 19 patients, p < 0.005) and Zivinice (14 against 3 patients, p < 0.005). Diffuse Large Cell Lymphoma (DLCL) was dominant in the test group with total of 73 patients (51%), and Small Cell Lymphoma was dominant in the control group with total of 33 patients (38%). Statistically significant increase of both DLCL and MALT lymphoma is found in the test group (p < 0.025), and the most frequent were patients with IV-B (18%), I-AE (15%) and II-BE (12%) clinical stadium, while in the control group the most frequent number of patients was in the clinical studia III-B (19%), II-B (14%) and IV-B (14%). The most prevalent stadium in both groups was B fenotype with 94% of cases in the test and 93% in the control group. The aggressive lymphomas are predominant in the test group (62%) while the indolent ones are predominant in the control group (64%). In both groups the most of the patients were with nodal primary presentation (51%). In the test group there was a significant increase of aggressive lymphoma in both men and women (p < 0.01).

DISCUSSION

In recent years, all NHL studies have shown an increase of the incidence in patients, especially in older age while the increase is not found only in infants. In our study the highest percentage of the incidence of NHL occurs in patients who are 55 and older that exactly matches the literature date. There is an increase of extranodal primary presentation (28%) in test group in comparison with the control group (18%). The distribution of the patients is not significantly different from the findings of the European Oncology Association from 2003 where it says that there are 54% of patients with primary nodal presentation, 34% of them with primary extranodal presentation and 12% combination of the two presentations. Recently, the most frequent presentation worldwide is in stomach, which is also proven in our research. In the test group the number of MALT and DLCL lymphoma located in stomach is in increase. In the last few years the dominant type of NHL worldwide is DLCL. Therefore the significant increase of the patients with this disease is noticed in our test group. The continuous increase of patients with aggressive NHL in the recent years has been noticed especially Lukavac, Tuzla and Zivinice. These are the regions where the electric plant and the chemical industry factories are located.

CONCLUSION

The incidence of NHL in the region of the North East Bosnia follows the world trend of the general increase of the NHL incidence including the significant increase in number of aggressive lymphoma. The frequency of DLCL and MALT lymphoma is evidently in increase. The significant changes in primary presentation of the disease have not been noticed. B phenotype of NHL is predominant in both periods of testing.

摘要

引言

非霍奇金淋巴瘤(NHL)是一组发病率持续上升的淋巴增殖性肿瘤。本文旨在分析波斯尼亚东北部NHL的免疫表型、临床分布、初次表现方式及生物学侵袭性。本文特别阐述了1998年至2002年的战后时期。

方法

本文分析了228例经病理组织学证实的NHL患者。试验组由1998年至2002年期间确诊为NHL的142例患者组成,对照组由1987年至1991年期间确诊为NHL的86例患者组成。分析了以下因素:采用链霉抗生物素蛋白间接三步免疫过氧化物酶免疫组化方法检测NHL的免疫表型、NHL类型、NHL的生物学侵袭程度、初次表现方式以及根据患者年龄、性别、职业和居住地(城市或农村)划分的疾病临床分期分布。确定了波斯尼亚东北部地区该疾病的患病率和发病率。采用平均值、标准差和卡方检验对数据进行统计分析。

结果

波斯尼亚东北部NHL患者总数试验组明显多于对照组,1989年发病率为2.6/10万居民,2002年为6.91/10万居民。试验组有80名男性(56%)和62名女性(44%),对照组有55名男性(64%)和31名女性(36%)。患者平均年龄为55.78±15.1岁。与对照组相比,试验组中工业和农业工人组患者数量有统计学意义的减少(分别为9%对15%和4%对19%,p<0.005)。同时,试验组中来自卢卡瓦茨工业区(15例对4例,p<0.005)、图兹拉(49例对19例,p<0.005)和日维尼察(14例对3例,p<0.005)的患者数量显著增加。弥漫性大细胞淋巴瘤(DLCL)在试验组中占主导地位,共有73例患者(51%),小细胞淋巴瘤在对照组中占主导地位,共有33例患者(38%)。试验组中DLCL和黏膜相关淋巴组织淋巴瘤(MALT淋巴瘤)均有统计学意义的增加(p<0.025),最常见的临床分期为IV - B期(18%)、I - AE期(15%)和II - BE期(12%),而对照组中最常见的临床分期为III - B期(19%)、II - B期(14%)和IV - B期(14%)。两组中最常见分期均为B表型,试验组94%的病例为此表型,对照组为93%。侵袭性淋巴瘤在试验组中占主导(62%),而惰性淋巴瘤在对照组中占主导(64%)。两组中大多数患者为淋巴结初次表现(51%)。试验组中男性和女性侵袭性淋巴瘤均有显著增加(p<0.01)。

讨论

近年来,所有NHL研究均显示患者发病率上升,尤其是老年患者,而仅婴儿发病率未增加。在我们的研究中,NHL发病率最高的百分比出现在55岁及以上患者中,这与文献数据完全相符。试验组中结外初次表现的比例(28%)高于对照组(18%)。患者分布与2003年欧洲肿瘤协会的研究结果无显著差异,该协会称54%的患者为淋巴结初次表现,34%为结外初次表现,12%为两者结合的表现。目前全球最常见的表现部位是胃,我们的研究也证实了这一点。试验组中位于胃的MALT淋巴瘤和DLCL淋巴瘤数量增加。近年来全球NHL的主要类型是DLCL。因此,我们试验组中该疾病患者数量显著增加。近年来侵袭性NHL患者持续增加,尤其是在卢卡瓦茨、图兹拉和日维尼察。这些是发电厂和化工厂所在的地区。

结论

波斯尼亚东北部地区NHL发病率遵循全球NHL发病率总体上升的趋势,包括侵袭性淋巴瘤数量的显著增加。DLCL和MALT淋巴瘤的发病率明显上升。疾病初次表现未发现显著变化。两个检测时期NHL的B表型均占主导。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验